Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices

被引:103
|
作者
Jutabha, R
Jensen, DM
Martin, P
Savides, T
Han, SH
Gornbein, J
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Hlth Sci Ctr, Dept Med,Div Digest Dis, Los Angeles, CA USA
[2] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[3] Univ Calif San Diego, Med Ctr, Ctr Ulcer Res & Educ, Digest Dis Res Ctr, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Med Ctr, Cedars Sinai Med Ctr, San Diego, CA 92103 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA
关键词
D O I
10.1053/j.gastro.2005.01.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Standard care for prevention of first esophageal variceal hemorrhage is beta-blockade, but this may be ineffective or unsafe. Our purpose was to compare endoscopic banding with propranolol for prevention of first variceal hemorrhage. Methods: In a multicenter, prospective trial, 62 patients with cirrhosis with high-risk esophageal varices were randomized to propranolol (titrated to reducing resting pulse by 25%) or banding (performed monthly until varices were eradicated) and were followed up on the same schedule for a mean duration of 15 months. The primary end point was treatment failure, defined as the development of endoscopically documented variceal hemorrhage or a severe medical complication requiring discontinuation of therapy. Direct costs were estimated from Medicare reimbursements and fixed or variable charges for services up to treatment failure. Results: Background variables of the treatment groups were similar. The trial was stopped early after an interim analysis showed that the failure rate of propranolol was significantly higher than that of banding (6/31 vs. 0/31; difference, 1.9.4%; P =.0098; 95% confidence interval for true difference, 6.4%-37.2%). Significantly more propranolol than banding patients had esophageal variceal hemorrhage (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%), and the cumulative mortality rate was significantly higher in the propranolol than in the banding group (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%). Direct costs of care were not significantly different. Conclusions: For patients with cirrhosis with high-risk esophageal varices and no history of variceal hemorrhage, propranolol-treated patients had significantly higher failure rates of failure, first esophageal varix hemorrhage, and cumulative mortality than banding patients. Direct costs of medical care were not significantly different.
引用
收藏
页码:870 / 881
页数:12
相关论文
共 50 条
  • [1] Initial report of a randomized, prospective study of prophylactic propranolol compared to rubber band ligation for prevention of first variceal hemorrhage in cirrhotics with large esophageal varices.
    Jutabha, R
    Jensen, DM
    Martin, P
    Savides, TJ
    Lam, F
    Jensen, ME
    Alofaituli, G
    Gornbein, J
    GASTROENTEROLOGY, 2000, 118 (04) : A212 - A213
  • [2] Prophylactic endoscopic variceal ligation of esophageal varices with high-risk of hemorrhage
    Lee, OJ
    Lee, JH
    Kim, KH
    GASTROENTEROLOGY, 1997, 112 (04) : A1316 - A1316
  • [3] A randomized, prospective study of prophylactic rubber band ligation compared to propranolol for prevention of first variceal hemorrhage in cirrhotics with large esophageal varices
    Jutabha, R
    Jensen, DM
    Martin, P
    Savides, TJ
    Chapman, L
    Jensen, ME
    Alofaituli, G
    Gornbein, J
    Han, S
    Saab, S
    GASTROINTESTINAL ENDOSCOPY, 2001, 53 (05) : AB70 - AB70
  • [4] PROPRANOLOL (PR) ALONE VERSUS THE COMBINATION OF ENDOSCOPIC SCLEROTHERAPY (ES) AND PROPRANOLOL IN THE PRIMARY PREVENTION OF VARICEAL HEMORRHAGE IN CIRRHOTICS WITH VARICES - A MULTICENTER, RANDOMIZED TRIAL
    AVGERINOS, A
    ARMONIS, A
    MANOLAKOPOULOS, S
    REKOUMIS, G
    ARGIRAKIS, G
    ADAMOPOULOS, A
    KANAGHINIS, I
    RAPTIS, S
    GASTROENTEROLOGY, 1995, 108 (04) : A1027 - A1027
  • [5] Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial
    Lo, GH
    Lai, KH
    Cheng, JS
    Lin, CK
    Hsu, PI
    Chiang, HT
    JOURNAL OF HEPATOLOGY, 1999, 31 (03) : 451 - 456
  • [6] Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis
    Taher, Mohamed Yousri
    El-Hadidi, Abeer
    EI-Shendidia, Assem
    Sedky, Ahmed
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2022, 29 (02) : 82 - 95
  • [7] A prospective randomized trial between the prophylactic endoscopic variceal ligation and propranolol administration for prevention of first bleeding in cirrhotic patients with high-risk esophageal varices
    Song, IH
    Shin, JW
    Kim, IH
    Choi, J
    Lim, CY
    Kim, JW
    Roe, IH
    JOURNAL OF HEPATOLOGY, 2000, 32 : 41 - 41
  • [8] Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices
    Lay, CS
    Tsai, YT
    Teg, CY
    Shyu, WS
    Guo, WS
    Wu, KL
    Lo, KJ
    HEPATOLOGY, 1997, 25 (06) : 1346 - 1350
  • [9] A Prospective Randomized Study on the Risk of Bacteremia in Banding versus Sclerotherapy of Esophageal Varices
    Zuckerman, Marc J.
    Jia, Yi
    Hernandez, Jesus A.
    Kolli, Venkateswara R.
    Norte, Arturo
    Amin, Hemal
    Casner, Nancy A.
    Dwivedi, Alok
    Ho, Hoi
    FRONTIERS IN MEDICINE, 2016, 3
  • [10] PROPHYLACTIC BANDING LIGATION OF HIGH-RISK ESOPHAGEAL-VARICES - AN INTERIM-REPORT
    LO, GH
    HWU, JH
    LAI, KH
    GASTROENTEROLOGY, 1995, 108 (04) : A1112 - A1112